Our Perspectives
THREAD Blog
How a Decentralized Clinical Trial Model Can Enhance Diversity in Oncology Research
The main difference between oncology research and every other therapeutic research area is that for a cancer patient, a clinical trial is the only option left after standard of care options are exhausted. The unfortunate fact is that most cancer patients still do not have access to clinical trials as further hope for treatment because of where they live.
Three Tips for Successful eCOA in Global, Decentralized Oncology Trials
The idea behind implementing decentralized clinical trial (DCT) approaches in oncology trials is to improve the participant experience. While participants may still need to visit clinics to receive infusion medications in most oncology studies, DCT elements can ease their trial burden by collecting data remotely in between visits. A key component of this strategy is the effective use of electronic clinical outcome assessments (eCOA).